Transaminase Inhibition by 2-Hydroxyglutarate Impairs Glutamate Biosynthesis and Redox Homeostasis in Glioma

McBrayer, Samuel K., Mayers, Jared R., DiNatale, Gabriel J., Shi, Diana D., Khanal, Januka, Chakraborty, Abhishek A., Sarosiek, Kristopher A., Briggs, Kimberly J. +19 more·2018·Cell
DOI 10.1016/j.cell.2018.08.038

Cited by (361)

Items 101–200 of 361

  1. Emerging role of ferroptosis in glioblastoma: Therapeutic opportunities and challenges
    Shenghua Zhuo, Guiying He, Taixue Chen, Xiang Li, Yunheng Liang, Wenkai Wu, Lingxiao Weng, Jigao Feng, Zhenzhong Gao, Kun Yang · 2022 · Frontiers in Molecular Biosciences
  2. Role of Glycolytic and Glutamine Metabolism Reprogramming on the Proliferation, Invasion, and Apoptosis Resistance through Modulation of Signaling Pathways in Glioblastoma
    Cristina Trejo‐Solís, Daniela Silva‐Adaya, Norma Serrano-García, Roxana Magaña-Maldonado, Dolores Jiménez‐Farfán, Elizabeth Ferreira-Guerrero, Arturo Cruz-Salgado, Rosa Angélica Castillo‐Rodríguez · 2023 · International Journal of Molecular Sciences
  3. IDH Mutations in Glioma: Molecular, Cellular, Diagnostic, and Clinical Implications
    Kristian A. Choate, Evan P.S. Pratt, Matthew James Jennings, Robert J. Winn, Paul B. Mann · 2024 · Biology
  4. Metabolic Profiling of Formalin-Fixed Paraffin-Embedded Tissues Discriminates Normal Colon from Colorectal Cancer
    Kota Arima, Mai Chan Lau, Melissa M. Zhao, Koichiro Haruki, Keisuke Kosumi, Kosuke Mima, Mancang Gu, Juha P. Väyrynen, Tyler S. Twombly, Yoshifumi Baba et al. · 2020 · Molecular Cancer Research
  5. IDH Inhibitors and Beyond: The Cornerstone of Targeted Glioma Treatment
    Lidia Gatto, Enrico Franceschi, Alicia Tosoni, Vincenzo Di Nunno, Ilaria Maggio, Raffaele Lodi, Alba Ariela Brandes · 2021 · Molecular Diagnosis & Therapy
  6. Dysregulation in the Brain Protein Profile of Zebrafish Lacking the Parkinson’s Disease-Related Protein DJ-1
    Amanda J. Edson, Helena A. Hushagen, Ann Kristin Frøyset, Inga Elda, Essa Ahsan Khan, Antonio Di Stefano, Kari Espolin Fladmark · 2019 · Molecular Neurobiology
  7. BCAT1 affects mitochondrial metabolism independently of leucine transamination in activated human macrophages
    Jeong‐Hun Ko, Antoni Olona, Adonia E. Papathanassiu, Norzawani B Buang, Kwon-Sik Park, Ana S.H. Costa, Claudio Mauro, Christian Frezza, Jacques V. Behmoaras · 2020 · Journal of Cell Science
  8. Ruscogenin Alleviates Myocardial Ischemia-Induced Ferroptosis through the Activation of BCAT1/BCAT2
    Fei Fu, Qiong Lai, Jingui Hu, Lu Zhang, Xiaozhou Zhu, Junping Kou, Boyang Yu, Fang Li · 2022 · Antioxidants
  9. Protein Kinase B (PKB/AKT) Protects IDH-Mutated Glioma from Ferroptosis via Nrf2
    Yang Liu, Fu-Ju Chou, Fengchao Lang, Meili Zhang, Hua Song, Wei Zhang, Dionne L. Davis, Nicole Briceno, Yang Zhang, Patrick Joseph Cimino et al. · 2023 · Clinical Cancer Research
  10. Dnmt3a loss and Idh2 neomorphic mutations mutually potentiate malignant hematopoiesis
    Xiaotian Zhang, Xinyu Wang, Xue Qing David Wang, Jianzhong Su, Nagireddy Putluri, Ting Zhou, Ying Qu, Mira Jeong, Anna G. Guzman, Carina Rosas et al. · 2020 · Blood
  11. Barriers to Immunotherapy in Ovarian Cancer: Metabolic, Genomic, and Immune Perturbations in the Tumour Microenvironment
    Racheal Louise Johnson, Michele Cummings, Amudha Thangavelu, Georgios Theophilou, Diederick De Jong, Nicolas Michel Orsi · 2021 · Cancers
  12. Anti-neoplastic Potential of Flavonoids and Polysaccharide Phytochemicals in Glioblastoma
    Ayesha Atiq, Ishwar S. Parhar · 2020 · Molecules
  13. Translational significance of CDKN2A/B homozygous deletion in isocitrate dehydrogenase-mutant astrocytoma
    Shannon P. Fortin Ensign, Robert Brian Jenkins, Caterina Giannini, Jann Nagina Sarkaria, Evanthia Galanis, Sani Haider Kizilbash · 2022 · Neuro-Oncology
  14. Development of tumor-evolution-targeted anticancer therapeutic nanomedicineEVT
    Lingpu Zhang, Jia‐Zhen Yang, Jia Huang, Yingjie Yu, Jianxun Ding, Johannes Karges, Haihua Xiao · 2024 · Chem
  15. TCA cycle-derived oncometabolites in cancer and the immune microenvironment
    Shukla Sarkar, Chien-I Chang, Jussekia Jean, Meng‐Ju Wu · 2025 · Journal of Biomedical Science
  16. Magnetic resonance spectroscopy for the study of cns malignancies
    Victor Ruiz‐Rodado, Jeffrey Brender, Murali Krishna Cherukuri, Mark R. Gilbert, Mioara Larion · 2020 · Progress in Nuclear Magnetic Resonance Spectroscopy
  17. From Laboratory Studies to Clinical Trials: Temozolomide Use in IDH-Mutant Gliomas
    Xueyuan Sun, Şevin Turcan · 2021 · Cells
  18. Wild-type IDH2 is a therapeutic target for triple-negative breast cancer
    Jiangjiang Li, T. Semiglazova Yu., Peiting Zeng, Jingyu Tian, Panpan Liu, Shuang Qiao, Shijun Wen, Yumin Hu, Qiao Liu, Wenhua Lu et al. · 2024 · Nature Communications
  19. Oxidative Stress and Antioxidants in Glioblastoma: Mechanisms of Action, Therapeutic Effects and Future Directions
    Agnieszka Nowacka, Maciej Śniegocki, Ewa Ziółkowska · 2025 · Antioxidants
  20. Take Advantage of Glutamine Anaplerosis, the Kernel of the Metabolic Rewiring in Malignant Gliomas
    Filipa Martins, Luís G. Gonçalves, Marta Pojo, Jacinta Serpa · 2020 · Biomolecules
  21. Rapid detection of IDH mutations in gliomas by intraoperative mass spectrometry
    Wei Hua, Wenpeng Zhang, Hannah Marie Brown, Junhan Wu, Xinqi Fang, Mahdiyeh Shahi, Rong Chen, Haoyue Zhang, Bin Jiao, Nan Wang et al. · 2024 · Proceedings of the National Academy of Sciences
  22. Altered Metabolism in Glioblastoma: Myeloid-Derived Suppressor Cell (MDSC) Fitness and Tumor-Infiltrating Lymphocyte (TIL) Dysfunction
    Natalia Di Ianni, Silvia Musio, Serena Pellegatta · 2021 · International Journal of Molecular Sciences
  23. A d-2-hydroxyglutarate biosensor based on specific transcriptional regulator DhdR
    Dan Xiao, Wen Zhang, Xiaoting Guo, Yidong Liu, Chunxia Hu, Shiting Guo, Zhaoqi Kang, Xianzhi Xu, Cuiqing Ma, Chao Gao et al. · 2021 · Nature Communications
  24. High-throughput analysis of tissue microarrays using automated desorption electrospray ionization mass spectrometry
    Nicolás M. Morato, Hannah Marie Brown, Diogo P. Moniz Garcia, Erik H. Middlebrooks, Mark E. Jentoft, Kaisorn Lee Chaichana, Alfredo Quiñones‐Hinojosa, R. Graham Cooks · 2022 · Scientific Reports
  25. Inborn errors of enzymes in glutamate metabolism
    Lynne Rumping, Esmee Vringer, Roderick H.J. Houwen, Peter M. van Hasselt, Judith J M Jans, Nanda M. Verhoeven‐Duif · 2019 · Journal of Inherited Metabolic Disease
  26. Characterization of dysregulated glutamine metabolism in human glioma tissue with 1H NMR
    Selin Ekici, Benjamin B. Risk, Stewart G. Neill, Hui‐Kuo G. Shu, Candace C. Fleischer · 2020 · Scientific Reports
  27. DNA damage response in brain tumors: A Society for Neuro-Oncology consensus review on mechanisms and translational efforts in neuro-oncology
    Rifaquat M. Rahman, Diana D. Shi, Zachary J. Reitman, Petra Hamerlik, John de Groot, Daphne Adele Haas-Kogan, Alan D. D’Andrea, Erik P. Sulman, Kirk G. Tanner, Nathalie Y.R. Agar et al. · 2024 · Neuro-Oncology
  28. Isocitrate dehydrogenase 1-mutated cancers are sensitive to the green tea polyphenol epigallocatechin-3-gallate
    Tom H. Peeters, Krissie Lenting, Vincent Breukels, Sanne A. M. van Lith, Corina N. A. M. van den Heuvel, Remco Jurriaan Molenaar, Arno van Rooij, Ron A. Wevers, Paul N. Span, Arend Heerschap et al. · 2019 · Cancer & Metabolism
  29. IDH1 Targeting as a New Potential Option for Intrahepatic Cholangiocarcinoma Treatment—Current State and Future Perspectives
    Fabiana Crispo, Michele Pietrafesa, Valentina Condelli, Francesca Maddalena, Giuseppina Bruno, Annamaria Piscazzi, Alessandro Sgambato, Franca Esposito, Matteo Landriscina · 2020 · Molecules
  30. YTHDF1 Promotes Cyclin B1 Translation through m6A Modulation and Contributes to the Poor Prognosis of Lung Adenocarcinoma with KRAS/TP53 Co-Mutation
    Xiaoying Lou, Jinfeng Ning, Wei Liu, Kexin Li, Benheng Qian, Danfei Xu, Yue Wu, Donghong Zhang, Wei Cui · 2021 · Cells
  31. Glucose and Amino Acid Metabolic Dependencies Linked to Stemness and Metastasis in Different Aggressive Cancer Types
    Andrea Nancy Chisari, Irene Golán, Sabrina Campisano, Caroline Gélabert, Aristidis Moustakas, Patricia Sancho, Laia Caja · 2021 · Frontiers in Pharmacology
  32. Targeting Isocitrate Dehydrogenase (IDH) in Solid Tumors: Current Evidence and Future Perspectives
    Francesca Carosi, Elisabetta Broseghini, Laura Fabbri, Giacomo Corradi, Riccardo Gili, Valentina Forte, Roberta Roncarati, Daria Maria Filippini, Manuela Ferracin · 2024 · Cancers
  33. Ferroptosis: iron release mechanisms in the bioenergetic process
    Jaewang Lee, Jong‐Lyel Roh · 2025 · Cancer and Metastasis Reviews
  34. Sphingolipid Pathway as a Source of Vulnerability in IDH1mut Glioma
    Tyrone Dowdy, Lumin Zhang, Orieta Celiku, Sriya Movva, Adrian Lita, Victor Ruiz‐Rodado, Mark R. Gilbert, Mioara Larion · 2020 · Cancers
  35. Cytosolic GDH1 degradation restricts protein synthesis to sustain tumor cell survival following amino acid deprivation
    Jialiang Shao, Tiezhu Shi, Hua Tao Yu, Yufeng Ding, Liping Li, Xiang Wang, Xiongjun Wang · 2021 · The EMBO Journal
  36. Wild-type IDH2 protects nuclear DNA from oxidative damage and is a potential therapeutic target in colorectal cancer
    Shuang Qiao, Wenhua Lu, Christophe Glorieux, Jiangjiang Li, Peiting Zeng, Ning Meng, Huiqin Zhang, Shijun Wen, Peng Huang · 2021 · Oncogene
  37. Emerging strategies to target cancer metabolism and improve radiation therapy outcomes
    Martin Kery, Ioanna Papandreou · 2020 · British Journal of Radiology
  38. Metabolic Regulation of the Epitranscriptome
    Justin M. Thomas, Pedro J. Batista, Jordan L. Meier · 2019 · ACS Chemical Biology
  39. Cysteine is a limiting factor for glioma proliferation and survival
    Victor Ruiz‐Rodado, Tyrone Dowdy, Adrian Lita, Tamalee R. Kramp, Meili Zhang, Jinkyu Jung, Ana Dios‐Esponera, Lumin Zhang, Christel C. Herold‐Mende, Kevin A. Camphausen et al. · 2021 · Molecular Oncology
  40. The biological essence of synthetic lethality: Bringing new opportunities for cancer therapy
    Meiyi Ge, Jian Luo, Yi Wu, Guobo Shen, Xi Kuang · 2024 · MedComm – Oncology
  41. Genetic and epigenetic instability as an underlying driver of progression and aggressive behavior in IDH-mutant astrocytoma
    Timothy E. Richardson, Jamie M. Walker, Dolores Hambardzumyan, Steven S. Brem, Kimmo J. Hatanpaa, Mariano Sebastian Viapiano, Balagopal Pai, Melissa Umphlett, Oren Josh Becher, Matija Snuderl et al. · 2024 · Acta Neuropathologica
  42. Sirtuin activation targets IDH-mutant tumors
    Julie J. Miller, Alexandria L. Fink, Jack A Banagis, Hiroaki Nagashima, Megha P. Subramanian, Christine Kyuyoung Lee, Lisa Melamed, Shilpa S. Tummala, Kensuke Tateishi, Hiroaki Wakimoto et al. · 2020 · Neuro-Oncology
  43. Glutaminase isoforms expression switches microRNA levels and oxidative status in glioblastoma cells
    Juan de los Santos-Jiménez, José Angel Campos-Sandoval, Clara Márquez-Torres, Nieves Urbano-Polo, David Brøndegaard, Mercedes Martín‐Rufián, Carolina Lobo, Ana Peñalver, María C. Gómez-García, Janet Martín-Campos et al. · 2021 · Journal of Biomedical Science
  44. L-type amino acid transporter 1 as a target for inflammatory disease and cancer immunotherapy
    Keitaro Hayashi, Naohiko Anzai · 2021 · Journal of Pharmacological Sciences
  45. Metabolism pathway-based subtyping in endometrial cancer: An integrated study by multi-omics analysis and machine learning algorithms
    Xiaodie Liu, Wenhui Wang, Xiaolei Zhang, Jing Liang, Feng Dingqing, Yuebo Li, Ming Xue, Bin Ling · 2024 · Molecular Therapy — Nucleic Acids
  46. Oncometabolites in cancer: from cancer cells to the tumor microenvironment
    Luoyi Chen, Min Huang · 2024 · Holistic Integrative Oncology
  47. Glutaminolysis dynamics during astrocytoma progression correlates with tumor aggressiveness
    Yollanda Edwirges Moreira Franco, Maria José Ferreira Alves, Miyuki Uno, Isabele Fattori Moretti, Marina Trombetta-Lima, Suzana de Siqueira Santos, Ancély Ferreira dos Santos, Gabriel Santos Arini, Maurı́cio S. Baptista, Antônio Marcondes Lerário et al. · 2021 · Cancer & Metabolism
  48. BCAT1 redox function maintains mitotic fidelity
    Liliana Francois, Pavle Boskovic, Julian Knerr, Wei He, Gianluca Sigismondo, Carsten Schwan, Tushar H. More, Magdalena Schlotter, Myra E. Conway, Jeroen Krijgsveld et al. · 2022 · Cell Reports
  49. Metabolic flux analysis and fluxomics-driven determination of reaction free energy using multiple isotopes
    Jimmy P. Xu, Julia I. Martien, Cole Gilbertson, Jun‐Yu Ma, Daniel Amador‐Noguez, Junyoung O. Park · 2020 · Current Opinion in Biotechnology
  50. Energy Metabolism in IDH1 Wild-Type and IDH1-Mutated Glioblastoma Stem Cells: A Novel Target for Therapy?
    Cornelis J.F. Van Noorden, Vashendriya V.V. Hira, Amber J. van Dijck, Metka Novak, Barbara Breznik, Remco Jurriaan Molenaar · 2021 · Cells
  51. Oncometabolite 2-hydroxyglutarate regulates anti-tumor immunity
    Mengyuan Cai, Jianyi Zhao, Qiang Ding, Jifu Wei · 2024 · Heliyon
  52. Targeting Isocitrate Dehydrogenase Mutations in Cancer: Emerging Evidence and Diverging Strategies
    Matthew S. Waitkus, Hai Yan · 2020 · Clinical Cancer Research
  53. Distinct and opposite effects of leukemogenic Idh and Tet2 mutations in hematopoietic stem and progenitor cells
    Jérôme Fortin, Ming-Feng Chiang, Cem Meydan, Jonathan Foox, Parameswaran Ramachandran, Julie Leca, François Lemonnier, Wanda Y. Li, Miki S. Gams, Takashi Sakamoto et al. · 2023 · Proceedings of the National Academy of Sciences
  54. 2-Hydroxyglutarate destabilizes chromatin regulatory landscape and lineage fidelity to promote cellular heterogeneity
    Meena Kusi, Maryam Zand, Li‐Ling Lin, Meizhen Chen, Anthony Lopez, Chun-Lin Lin, Chiou‐Miin Wang, Nicholas L. L. Lucio, Nameer B. Kirma, Jianhua Ruan et al. · 2022 · Cell Reports
  55. Precision Oncology in Lower-Grade Gliomas: Promises and Pitfalls of Therapeutic Strategies Targeting IDH-Mutations
    Pasquale Persico, Elena Lorenzi, Agnese Losurdo, Angelo Dipasquale, Antonio Di Muzio, Pierina Navarria, Federico Pessina, Letterio Salvatore Politi, Giuseppe Lombardi, Armando Santoro et al. · 2022 · Cancers
  56. Ferroptosis in Glioma Immune Microenvironment: Opportunity and Challenge
    Kaikai Wang, Junjie Wang, Jiahao Zhang, Anke Zhang, Yibo Liu, Jingyi Zhou, Xiaoyu Wang, Jianmin Zhang · 2022 · Frontiers in Oncology
  57. Inhibition of mutant IDH1 promotes cycling of acute myeloid leukemia stem cells
    Emily Gruber, Joan So, Alexander Charles Lewis, Rheana L. Franich, Rachel Cole, Luciano Gastón Martelotto, Amy J. Rogers, Eva Vidacs, Peter Fraser, Kym L. Stanley et al. · 2022 · Cell Reports
  58. Preclinical and Clinical Applications of Metabolomics and Proteomics in Glioblastoma Research
    Munazza Ahmed, Ahlam M. Semreen, Waseem El‐Huneidi, Yasser Khalil Bustanji, Eman Abu‐Gharbieh, Mohammad A. Y. Alqudah, Ahmed Alhusban, Mohd Shara, Ahmad Y. Abuhelwa, Nelson Cruz Soares et al. · 2022 · International Journal of Molecular Sciences
  59. GLS and GLS2 Glutaminase Isoenzymes in the Antioxidant System of Cancer Cells
    Juan de los Santos-Jiménez, José Angel Campos-Sandoval, Francisco José Alonso, Javier Márquez, José Manuel Matés · 2024 · Antioxidants
  60. Targeting Amino Acid Metabolic Vulnerabilities in Myeloid Malignancies
    Livingstone Fultang, Luciana Gneo, Carmela De Santo, Francis Mussai · 2021 · Frontiers in Oncology
  61. Glioblastoma Metabolomics—In Vitro Studies
    Karol Jaroch, Paulina Modrakowska, Barbara Bojko · 2021 · Metabolites
  62. The Roles of IDH1 in Tumor Metabolism and Immunity
    Yingqian Ni, Peibo Shen, Xingchen Tony Wang, He Liu, Huiyuan Luo, Xiuzhen Han · 2022 · Future Oncology
  63. Glutamine Metabolism and Prostate Cancer
    Holger H.H. Erb, Nikita Polishchuk, Oleh V. Stasyk, Uğur Kahya, Matthias M Weigel, Anna Dubrovska · 2024 · Cancers
  64. Epigenetic regulation by endogenous metabolite pharmacology
    Rhushikesh A. Kulkarni, David C. Montgomery, Jordan L. Meier · 2019 · Current Opinion in Chemical Biology
  65. Quantification and 13C-Tracer analysis of total reduced glutathione by HPLC-QTOFMS/MS
    Xueni Sun, Paul Heinrich, Raffaela S. Berger, Peter Josef Oefner, Katja Dettmer · 2019 · Analytica Chimica Acta
  66. Role of amino acids in regulation of ROS balance in cancer
    Emilie Jaune, Sophie Vasseur · 2020 · Archives of Biochemistry and Biophysics
  67. Metabolic partitioning in the brain and its hijacking by glioblastoma
    Jed de Ruiter Swain, Evdokia Michalopoulou, Evan Noch, Michael J. Lukey, Linda Van Aelst · 2023 · Genes & Development
  68. Further understanding of glioma mechanisms of pathogenesis: implications for therapeutic development
    Michael W. Ruff, Sani Haider Kizilbash, Jan C. Buckner · 2020 · Expert Review of Anticancer Therapy
  69. DNA damage in IDH-mutant gliomas: mechanisms and clinical implications
    Diana D. Shi, Soummitra Anand, Kalil G. Abdullah, Samuel K. McBrayer · 2022 · Journal of Neuro-Oncology
  70. L-2hydroxyglutaric acid rewires amino acid metabolism in colorectal cancer via the mTOR-ATF4 axis
    Sho Tabata, Yasushi Kojima, Takeharu Sakamoto, Kaori Igarashi, Ko Umetsu, Takamasa Ishikawa, Akiyoshi Hirayama, Rie Kajino‐Sakamoto, Naoya Sakamoto, Ken‐ichi Yasumoto et al. · 2023 · Oncogene
  71. Single-cell and spatial transcriptome assays reveal heterogeneity in gliomas through stress responses and pathway alterations
    Zongze He, Zheng Liu, Qi Wang, Xingjian Sima, Wei Zhao, Chunmei He, Wenjie Yang, Han Chen, Bo Gong, Siyuan Song et al. · 2024 · Frontiers in Immunology
  72. Stable isotope tracing in human plasma-like medium reveals metabolic and immune modulation of the glioblastoma microenvironment
    Milan R. Savani, Mohamad El Shami, Kenji Miki, Lauren C. Gattie, Bailey C. Smith, William Harrison Hicks, Jacob Weiss, Skyler Oken, Lavanya N Katta, Tracey E. Shipman et al. · 2025 · Neuro-Oncology
  73. Metabolic plasticity of IDH1-mutant glioma cell lines is responsible for low sensitivity to glutaminase inhibition
    Victor Ruiz‐Rodado, Adrian Lita, Tyrone Dowdy, Orieta Celiku, Alejandra Cavazos Saldana, Herui Wang, Chunzhang Yang, Raj Chari, Aiguo Li, Wei Zhang et al. · 2020 · Cancer & Metabolism
  74. Leveraging and manufacturing in vitro multicellular spheroid-based tumor cell model as a preclinical tool for translating dysregulated tumor metabolism into clinical targets and biomarkers
    Tong Wang, Lin Wang, Guan Wang, Yingping Zhuang · 2020 · Bioresources and Bioprocessing
  75. BCAT2 binding to PCBP1 regulates the PI3K/AKT signaling pathway to inhibit autophagy-related apoptosis and ferroptosis in prostate cancer
    Wangli Mei, Mengyu Wei, Chaozhi Tang, Weiyi Li, Bowen Ye, Shiyong Xin, Weiguo Ma, Lin Ye · 2025 · Cell Death and Disease
  76. Metabolic Reprogramming and Its Relationship to Survival in Hepatocellular Carcinoma
    Qingqing Wang, Yexiong Tan, Tianyi Jiang, Xiaolin Wang, Qi Li, Yanli Li, Liwei Dong, Xinyu Liu, Guowang Xu · 2022 · Cells
  77. Targeting oncometabolism to maximize immunotherapy in malignant brain tumors
    Joshua D. Bernstock, Kyung‐Don Kang, Neil V. Klinger, Hannah E. Olsen, Sam E. Gary, Stacie K. Totsch, Gelare Ghajar-Rahimi, David J. Segar, Eric M. Thompson, Victor M. Darley-Usmar et al. · 2022 · Oncogene
  78. Blood-brain barrier disruption defines the extracellular metabolome of live human high-grade gliomas
    Cécile Riviere-Cazaux, Lucas P. Carlstrom, Karishma R. Rajani, Amanda Munoz-Casabella, Masum Rahman, Ali Gharibi Loron, Desmond A. Brown, Kai Joshua Miller, Jaclyn J. White, Benjamin T. Himes et al. · 2023 · Communications Biology
  79. The two enantiomers of 2-hydroxyglutarate differentially regulate cytotoxic T cell function
    Iosifina P. Foskolou, Pedro P. Cunha, Elena Sánchez‐López, Eleanor Minogue, Benoît P. Nicolet, Aurélie Guislain, Christian Jorgensen, Sarantos Kostidis, Nordin D. Zandhuis, Laura Barbieri et al. · 2023 · Cell Reports
  80. Metabolism and signaling crosstalk in glioblastoma progression and therapy resistance
    Laura Zarzuela, Raúl V. Durán, Mercedes Tomé · 2023 · Molecular Oncology
  81. Metabolic remodeling by the PD-L1 inhibitor BMS-202 significantly inhibits cell malignancy in human glioblastoma
    Xueou Yang, Wenjun Wang, Tianhai Ji · 2024 · Cell Death and Disease
  82. Enrichment of branched chain amino acid transaminase 1 correlates with multiple biological processes and contributes to poor survival of IDH1 wild-type gliomas
    Yi Li, Xiaoguang Fan, Jiabo Li, Feng Yuan, Jian Zhao, Monica Nistér, Xuejun Yang · 2021 · Aging
  83. Cystathionine-γ-lyase drives antioxidant defense in cysteine-restricted IDH1-mutant astrocytomas
    Andrés Cano-Galiano, Anaïs Oudin, Fred Fack, Maria Francesca Allega, David P. Sumpton, Elena Martínez-García, Gunnar A. G. Dittmar, Ann‐Christin Hau, Alfonso De Falco, Christel C. Herold‐Mende et al. · 2021 · Neuro-Oncology Advances
  84. Metabolic expression profiling stratifies diffuse lower-grade glioma into three distinct tumour subtypes
    Fan Wu, Yanwei Liu, Guanzhang Li, You Zhai, Yuemei Feng, Wenping Ma, Zheng Zhao, Wei Zhang · 2021 · British Journal of Cancer
  85. Fueling the fight against cancer: Exploring the impact of branched-chain amino acid catalyzation on cancer and cancer immune microenvironment
    Qianquan Ma, Haoyu Li, Zhihao Song, Zhili Deng, Wei Huang, Qing Liu · 2024 · Metabolism
  86. Perioperative IDH inhibition in treatment-naive IDH-mutant glioma: a pilot trial
    Katharine Jann Drummond, Montana Spiteri, Sarah A. Cain, Jordan Jones, Sammy Shaya, Monique D. Topp, Tianyao Lu, Robert Tobler, Adam Valkovic, Zachery Moore et al. · 2025 · Nature Medicine
  87. Fermentative Production of l-2-Hydroxyglutarate by Engineered Corynebacterium glutamicum via Pathway Extension of l-Lysine Biosynthesis
    Carina Prell, Arthur Burgardt, Florian Meyer, Volker F. Wendisch · 2021 · Frontiers in Bioengineering and Biotechnology
  88. Targeting IDH1/IDH2 mutations in gliomas
    Macarena I. de la Fuente · 2022 · Current Opinion in Neurology
  89. Nuclear Translocation of LDHA Promotes the Catabolism of BCAAs to Sustain GBM Cell Proliferation through the TxN Antioxidant Pathway
    Zhujun Li, Zhiyan Gu, Lan Wang, Yun Guan, Yingying Lyu, Jialong Zhang, Yin Wang, Xin Wang, Ji Xiong, Ying Liu · 2023 · International Journal of Molecular Sciences
  90. Moonlighting Enzymes at the Interface Between Metabolism and Epigenetics
    Jan A. van der Knaap, C. Peter Verrijzer · 2025 · Annual Review of Biochemistry
  91. A Novel Four-Gene Signature Associated With Immune Checkpoint for Predicting Prognosis in Lower-Grade Glioma
    Youchao Xiao, Gang Cui, Xingguang Ren, Jiaqi Hao, Yu Zhang, Xin Yang, Zhuangzhuang Wang, Xiaolin Zhu, Huan Wang, Chunyan Hao et al. · 2020 · Frontiers in Oncology
  92. Differential expression of the BCAT isoforms between breast cancer subtypes
    Mai Ahmed Shafei, Arwa F. Flemban, Carl S. Daly, Paul Kendrick, Paul White, Sarah Dean, David Qualtrough, Myra E. Conway · 2020 · Breast Cancer
  93. The ferroptosis landscape in acute myeloid leukemia
    Zhixin Ma, Wenle Ye, Xin Huang, Xia Li, Fenglin Li, Xiangjie Lin, Chao Hu, Jinghan Wang, Jie Jin, Bo Zhu et al. · 2023 · Aging
  94. Glutamine metabolism and radiosensitivity: Beyond the Warburg effect
    Ryan S. Alden, Mohammad Zahid Kamran, Bassel Bashjawish, Brittany A. Simone · 2022 · Frontiers in Oncology
  95. A D-2-hydroxyglutarate dehydrogenase mutant reveals a critical role for ketone body metabolism in Caenorhabditis elegans development
    Olga Ponomarova, Hefei Zhang, Xuhang Li, Shivani Nanda, Thomas B. Leland, Bennett William Fox, Alyxandra N. Starbard, Gabrielle E. Giese, Frank C. Schroeder, Lutfu Safak Yilmaz et al. · 2023 · PLoS Biology
  96. Mitochondrial inhibitors: a new horizon in breast cancer therapy
    Yalan Yan, Sijie Li, Lanqian Su, Xinrui Tang, Xiaoyan Chen, Xiang Gu, Guanhu Yang, Hao Chi, Shangke Huang · 2024 · Frontiers in Pharmacology
  97. Teleological role of L-2-hydroxyglutarate dehydrogenase in the kidney
    Garrett J. Brinkley, Hyeyoung Nam, Eun‐Hee Shim, Richard L. Kirkman, Anirban Kundu, Suman Karki, Yasaman Heidarian, Jason M. Tennessen, Juan Liu, Jason W. Locasale et al. · 2020 · Disease Models & Mechanisms
  98. Isocitrate Dehydrogenase Mutations in Cancer: Mechanisms of Transformation and Metabolic Liability
    Kathryn Gunn, Julie-Aurore Losman · 2024 · Cold Spring Harbor Perspectives in Medicine
  99. Deciphering the multifaceted roles and clinical implications of 2-hydroxyglutarate in cancer
    Jie Hao, Ziyi Huang, Siyue Zhang, Kefan Song, Juncheng Wang, Chao Gao, Zhiqing Fang, Ning Zhang · 2024 · Pharmacological Research
  100. Panoramic spatial enhanced resolution proteomics (PSERP) reveals tumor architecture and heterogeneity in gliomas
    Ziyan Xu, Yunzhi Wang, Tao Xie, Rongkui Luo, Hengli Ni, Xiang Hang, Shaoshuai Tang, Subei Tan, Rundong Fang, Peng Ran et al. · 2025 · Journal of Hematology & Oncology